Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Moxidectin	6,421
Overall Study	STARTED	Ivermectin	1,605
Overall Study	STARTED	Moxidectin Plus Albendazole	3,959
Overall Study	STARTED	Ivermectin Plus Albendazole	994
Overall Study	COMPLETED	Moxidectin	6,395
Overall Study	COMPLETED	Ivermectin	1,592
Overall Study	COMPLETED	Moxidectin Plus Albendazole	3,891
Overall Study	COMPLETED	Ivermectin Plus Albendazole	977
Overall Study	NOT COMPLETED	Moxidectin	26
Overall Study	NOT COMPLETED	Ivermectin	13
Overall Study	NOT COMPLETED	Moxidectin Plus Albendazole	68
Overall Study	NOT COMPLETED	Ivermectin Plus Albendazole	17

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04311671/flow